Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Leukocyte L1 Antigen Complex | 5 | 2019 | 238 | 1.97 | Why? |
| Isometric Contraction | 2 | 2019 | 19 | 1.53 | Why? |
| Lipocalin-2 | 4 | 2019 | 156 | 1.50 | Why? |
| Hepatitis A Virus Cellular Receptor 1 | 3 | 2018 | 86 | 1.49 | Why? |
| Pancreas Transplantation | 2 | 2020 | 163 | 1.47 | Why? |
| Kidney Transplantation | 12 | 2021 | 5397 | 1.21 | Why? |
| Weightlessness | 2 | 2018 | 12 | 0.96 | Why? |
| Monitoring, Immunologic | 1 | 2020 | 153 | 0.79 | Why? |
| Immunity, Humoral | 5 | 2021 | 4849 | 0.79 | Why? |
| Nephrologists | 1 | 2020 | 117 | 0.76 | Why? |
| Graft Survival | 3 | 2018 | 587 | 0.76 | Why? |
| Graft Rejection | 3 | 2020 | 1766 | 0.76 | Why? |
| Kidney Glomerulus | 1 | 2020 | 144 | 0.75 | Why? |
| Kidney Tubular Necrosis, Acute | 1 | 2017 | 56 | 0.72 | Why? |
| Nephrotic Syndrome | 1 | 2020 | 146 | 0.71 | Why? |
| Meningoencephalitis | 1 | 2020 | 208 | 0.69 | Why? |
| Lipoproteins, HDL | 1 | 2019 | 154 | 0.68 | Why? |
| Calcineurin Inhibitors | 1 | 2018 | 218 | 0.68 | Why? |
| Vascular Stiffness | 2 | 2018 | 264 | 0.67 | Why? |
| ADAMTS13 Protein | 1 | 2021 | 363 | 0.67 | Why? |
| Glomerulonephritis, IGA | 1 | 2018 | 115 | 0.66 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.65 | Why? |
| Hand Strength | 1 | 2017 | 202 | 0.64 | Why? |
| Purpura, Thrombotic Thrombocytopenic | 1 | 2021 | 284 | 0.63 | Why? |
| Hyperuricemia | 1 | 2017 | 160 | 0.62 | Why? |
| Immunocompromised Host | 4 | 2021 | 5150 | 0.61 | Why? |
| Aorta | 1 | 2018 | 355 | 0.59 | Why? |
| von Willebrand Factor | 1 | 2021 | 668 | 0.57 | Why? |
| Cyclosporine | 1 | 2018 | 449 | 0.56 | Why? |
| Uric Acid | 1 | 2017 | 285 | 0.54 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.53 | Why? |
| BK Virus | 3 | 2019 | 135 | 0.50 | Why? |
| Rituximab | 1 | 2021 | 1096 | 0.50 | Why? |
| Acute Kidney Injury | 6 | 2019 | 5762 | 0.50 | Why? |
| Blood Pressure | 3 | 2019 | 2198 | 0.49 | Why? |
| Hypertension | 3 | 2019 | 8895 | 0.47 | Why? |
| Transplant Recipients | 3 | 2020 | 4982 | 0.40 | Why? |
| Insulin-Like Growth Factor Binding Proteins | 2 | 2019 | 35 | 0.38 | Why? |
| Tissue Inhibitor of Metalloproteinase-2 | 2 | 2019 | 45 | 0.38 | Why? |
| Polyomavirus Infections | 3 | 2019 | 156 | 0.37 | Why? |
| Exercise Therapy | 1 | 2017 | 976 | 0.37 | Why? |
| Exercise | 2 | 2019 | 6771 | 0.35 | Why? |
| Postoperative Complications | 3 | 2021 | 5861 | 0.33 | Why? |
| Germany | 7 | 2021 | 9196 | 0.31 | Why? |
| Immunologic Memory | 5 | 2021 | 3362 | 0.31 | Why? |
| Immunity, Cellular | 5 | 2021 | 3614 | 0.31 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.30 | Why? |
| Kidney | 2 | 2017 | 3648 | 0.30 | Why? |
| Biomarkers | 6 | 2019 | 23361 | 0.29 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.26 | Why? |
| Immunosuppressive Agents | 2 | 2018 | 6331 | 0.25 | Why? |
| Male | 32 | 2021 | 367725 | 0.22 | Why? |
| ROC Curve | 3 | 2018 | 6024 | 0.22 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.21 | Why? |
| T-Lymphocytes | 5 | 2021 | 6670 | 0.21 | Why? |
| Transplantation, Homologous | 2 | 2020 | 757 | 0.20 | Why? |
| Biopsy | 2 | 2020 | 2811 | 0.20 | Why? |
| Female | 30 | 2021 | 380317 | 0.19 | Why? |
| Indomethacin | 1 | 2019 | 47 | 0.19 | Why? |
| Ductus Arteriosus, Patent | 1 | 2019 | 32 | 0.19 | Why? |
| Space Flight | 1 | 2018 | 37 | 0.18 | Why? |
| Methods | 1 | 2017 | 19 | 0.18 | Why? |
| Aerospace Medicine | 1 | 2018 | 47 | 0.18 | Why? |
| Adult | 23 | 2021 | 244371 | 0.18 | Why? |
| Kidney Diseases | 2 | 2020 | 1434 | 0.18 | Why? |
| Vascular Resistance | 1 | 2018 | 148 | 0.17 | Why? |
| Cross-Over Studies | 1 | 2021 | 867 | 0.17 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.17 | Why? |
| Organ Transplantation | 3 | 2021 | 2616 | 0.17 | Why? |
| CD4-Positive T-Lymphocytes | 4 | 2020 | 4545 | 0.17 | Why? |
| Furosemide | 1 | 2017 | 99 | 0.17 | Why? |
| Humans | 41 | 2021 | 930598 | 0.16 | Why? |
| Atypical Hemolytic Uremic Syndrome | 1 | 2017 | 62 | 0.16 | Why? |
| Viral Structural Proteins | 1 | 2020 | 491 | 0.16 | Why? |
| Cross-Sectional Studies | 7 | 2020 | 53120 | 0.16 | Why? |
| Oxidation-Reduction | 1 | 2019 | 540 | 0.16 | Why? |
| Pulse Wave Analysis | 1 | 2017 | 221 | 0.16 | Why? |
| Radial Artery | 1 | 2017 | 132 | 0.16 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 552 | 0.16 | Why? |
| Bioprosthesis | 1 | 2017 | 126 | 0.15 | Why? |
| Cholesterol, HDL | 1 | 2019 | 439 | 0.15 | Why? |
| Adaptation, Physiological | 1 | 2018 | 359 | 0.15 | Why? |
| False Positive Reactions | 1 | 2020 | 1338 | 0.15 | Why? |
| Renal Dialysis | 3 | 2021 | 4358 | 0.15 | Why? |
| Urinalysis | 1 | 2017 | 218 | 0.14 | Why? |
| Aged | 19 | 2021 | 215776 | 0.14 | Why? |
| Herpesvirus 4, Human | 1 | 2018 | 387 | 0.14 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.14 | Why? |
| Remission Induction | 1 | 2018 | 950 | 0.14 | Why? |
| Virus Activation | 1 | 2019 | 480 | 0.14 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.13 | Why? |
| Case-Control Studies | 5 | 2021 | 17671 | 0.13 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.13 | Why? |
| Allografts | 1 | 2017 | 761 | 0.13 | Why? |
| Heart Valve Diseases | 1 | 2017 | 355 | 0.12 | Why? |
| Cytomegalovirus | 1 | 2018 | 600 | 0.12 | Why? |
| Cardiovascular Agents | 1 | 2019 | 663 | 0.12 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.12 | Why? |
| Donor Selection | 1 | 2018 | 804 | 0.11 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.11 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.11 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.11 | Why? |
| Heart Valve Prosthesis | 1 | 2017 | 533 | 0.11 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.11 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.11 | Why? |
| HLA Antigens | 1 | 2017 | 830 | 0.11 | Why? |
| Time Factors | 3 | 2019 | 31397 | 0.11 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2017 | 552 | 0.11 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.11 | Why? |
| Aortic Valve | 1 | 2017 | 664 | 0.11 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.11 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.10 | Why? |
| General Practitioners | 1 | 2017 | 568 | 0.10 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.10 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.10 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2021 | 5837 | 0.10 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.10 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.10 | Why? |
| Waiting Lists | 1 | 2017 | 1388 | 0.09 | Why? |
| Epitopes | 1 | 2020 | 4113 | 0.09 | Why? |
| Renal Replacement Therapy | 1 | 2017 | 1530 | 0.09 | Why? |
| Tumor Virus Infections | 2 | 2019 | 127 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.08 | Why? |
| Thermodilution | 1 | 2007 | 62 | 0.08 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.08 | Why? |
| Cross Reactions | 1 | 2019 | 4374 | 0.08 | Why? |
| Tissue Donors | 1 | 2017 | 1679 | 0.08 | Why? |
| Influenza A virus | 1 | 2019 | 2234 | 0.08 | Why? |
| Genetic Predisposition to Disease | 1 | 2021 | 4027 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.08 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.08 | Why? |
| Tissue and Organ Procurement | 1 | 2017 | 1277 | 0.08 | Why? |
| Antigens, Viral | 2 | 2020 | 6298 | 0.07 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.07 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.07 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.07 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.06 | Why? |
| T-Lymphocyte Subsets | 2 | 2020 | 1387 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.06 | Why? |
| Catheterization, Central Venous | 1 | 2007 | 458 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
| Matched-Pair Analysis | 1 | 2021 | 83 | 0.06 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.05 | Why? |
| Cytotoxins | 1 | 2020 | 57 | 0.05 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Hypergravity | 1 | 2018 | 5 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Infant, Newborn | 2 | 2019 | 23105 | 0.05 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.05 | Why? |
| Infant, Very Low Birth Weight | 1 | 2019 | 62 | 0.05 | Why? |
| Delayed Graft Function | 1 | 2018 | 52 | 0.05 | Why? |
| Cold Ischemia | 1 | 2018 | 37 | 0.05 | Why? |
| Microbial Interactions | 1 | 2018 | 67 | 0.05 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Infant, Low Birth Weight | 1 | 2019 | 243 | 0.04 | Why? |
| Granulocytes | 1 | 2018 | 140 | 0.04 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2018 | 325 | 0.04 | Why? |
| Herpesviridae Infections | 1 | 2018 | 172 | 0.04 | Why? |
| Histocompatibility Testing | 1 | 2017 | 219 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| Antigens, CD | 1 | 2020 | 984 | 0.04 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.04 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.03 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
| Creatinine | 1 | 2019 | 1443 | 0.03 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.03 | Why? |
| Membrane Glycoproteins | 1 | 2020 | 2273 | 0.03 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
| Critical Illness | 2 | 2020 | 17281 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.02 | Why? |
| Kinetics | 1 | 2018 | 3238 | 0.02 | Why? |
| Genotype | 1 | 2021 | 4697 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Leukocyte Count | 1 | 2018 | 3178 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2021 | 3607 | 0.02 | Why? |
| Child | 1 | 2017 | 70012 | 0.02 | Why? |
| Vena Cava, Superior | 1 | 2007 | 30 | 0.02 | Why? |
| Extravascular Lung Water | 1 | 2007 | 32 | 0.02 | Why? |
| Viral Load | 2 | 2018 | 15850 | 0.02 | Why? |
| Femoral Vein | 1 | 2007 | 43 | 0.02 | Why? |
| Jugular Veins | 1 | 2007 | 52 | 0.02 | Why? |
| Diastole | 1 | 2007 | 168 | 0.02 | Why? |
| Blood Volume | 1 | 2007 | 90 | 0.02 | Why? |
| Blood Flow Velocity | 1 | 2007 | 193 | 0.02 | Why? |
| Cardiac Output | 1 | 2007 | 183 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.02 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| Lung | 1 | 2007 | 31049 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Vaccination | 1 | 2019 | 19050 | 0.01 | Why? |
| Intensive Care Units | 1 | 2007 | 29594 | 0.00 | Why? |
Westhoff's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(160)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_